目的探讨术后综合干预在达芬奇机器人手术系统行纵隔肿瘤切除术患者预后上的优势。 方法选取2013年10月至2015年2月沈阳军区总医院行达芬奇机器人手术系统纵隔肿瘤切除术94例，随机分为干预组和对照组，每组各47例。对照组按胸外科一般常规予围手术期治疗与护理，干预组在此基础上实施针对此手术制定的综合术后干预策略。分析比较两组患者临床效果指标及生活质量。 结果干预组和对照组术后监护时间[（27.83±6.64）d vs.（55.85±14.97）d，P=0.000]、术后留置引流管时间[2（0～6）d vs.5（0～9）d，P=0.000]、术后疼痛评分（0.89±0.70 vs.2.83±0.92，P=0.000）、术后住院时间[（4.85±1.49）d vs.（8.11±1.94）d，P=0.000]、SAS评分（48.43±3.82 vs.57.66±3.42，P=0.000）、生活质量评分（38.06±3.24 vs.31.83±2.44，P=0.000）差异均有统计学意义。 结论术后综合干预加速了达芬奇机器人手术系统行纵隔肿瘤切除术术后患者的康复，提高了患者的生活质量。
This article reviews Chinese nomenclature of renal replacement therapy and extracorporeal blood purification currently utilized to manage acute kidney injury and other organ dysfunction syndromes in critically ill patients, based on the recent reports of a consensus expert conference of Nomenclature Standardization Initiative Alliance. We provide a detailed description of the performance characteristics of membranes, filters, transmembrane transport of solutes and fluid, flows, and methods of measurement of delivered treatment, common definitions, components, techniques, and operations of the machines and platforms as well as the renal replacement therapy techniques in detail with the relevant technologies, procedures, operations, and recent developments in other extracorporeal therapies, including therapeutic plasma exchange, multiple organ support therapy, liver support, lung support, and blood purification in sepsis. We believe this nomenclature review will serve future use of terminology in publications, research, clinical operations and therapy platforms to enable consistent data collection and comparison.